Ikena Oncology Inc (NASDAQ: IKNA) flaunted slowness of -8.38% at $1.53, before settling in for the price of $1.67 at the close. Taking a more long-term approach, IKNA posted a 52-week range of $1.22-$2.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 280.42%. Meanwhile, its Annual Earning per share during the time was -7.46%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 28.07%. This publicly-traded company’s shares outstanding now amounts to $48.26 million, simultaneously with a float of $27.31 million. The organization now has a market capitalization sitting at $67.64 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6893, while the 200-day Moving Average is $1.6050.
Ikena Oncology Inc (IKNA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Ikena Oncology Inc industry. Ikena Oncology Inc’s current insider ownership accounts for 43.40%, in contrast to 25.98% institutional ownership.
Ikena Oncology Inc (IKNA) Earnings and Revenue Records
Ikena Oncology Inc’s EPS increase for this current 12-month fiscal period is 28.07% and is forecasted to reach -1.03 in the upcoming year.
Ikena Oncology Inc (NASDAQ: IKNA) Trading Performance Indicators
Let’s observe the current performance indicators for Ikena Oncology Inc (IKNA). It’s Quick Ratio in the last reported quarter now stands at 15.32. The Stock has managed to achieve an average true range (ATR) of 0.10. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 102.49.
In the same vein, IKNA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.24, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -1.03 at the market close of one year from today.
Technical Analysis of Ikena Oncology Inc (IKNA)
Now, what If we examine the latest scores posted by [Ikena Oncology Inc, IKNA]. During the last 5-days, its volume was better the volume of 0.25 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 18.72% While, its Average True Range was 0.1164.
Raw Stochastic average of Ikena Oncology Inc (IKNA) in the period of the previous 100 days is set at 4.65%, which indicates a major rise in contrast to 4.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 58.30% that was higher than 32.55% volatility it exhibited in the past 100-days period.
